Evotec SE Statistics

Total Valuation

Evotec SE has a market cap or net worth of GBP 1.11 billion. The enterprise value is 1.15 billion.

Market Cap	1.11B
Enterprise Value	1.15B

Important Dates

The last earnings date was Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.69
PB Ratio	1.41
P/TBV Ratio	2.09
P/FCF Ratio	n/a
P/OCF Ratio	73.89
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 75.38, with an EV/FCF ratio of -14.01.

EV / Earnings	-7.09
EV / Sales	1.69
EV / EBITDA	75.38
EV / EBIT	n/a
EV / FCF	-14.01

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.46.

Current Ratio	1.98
Quick Ratio	1.74
Debt / Equity	0.46
Debt / EBITDA	19.81
Debt / FCF	-4.43
Interest Coverage	-6.75

Financial Efficiency

Return on equity (ROE) is -18.92% and return on invested capital (ROIC) is -3.14%.

Return on Equity (ROE)	-18.92%
Return on Assets (ROA)	-2.37%
Return on Invested Capital (ROIC)	-3.14%
Return on Capital Employed (ROCE)	-5.03%
Revenue Per Employee	139,044
Profits Per Employee	-34,209
Employee Count	4,740
Asset Turnover	0.38
Inventory Turnover	22.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.35% in the last 52 weeks. The beta is 1.09, so Evotec SE's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-49.35%
50-Day Moving Average	6.90
200-Day Moving Average	7.39
Relative Strength Index (RSI)	63.20
Average Volume (20 Days)	43,016

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Evotec SE had revenue of GBP 659.07 million and -162.15 million in losses. Loss per share was -0.92.

Revenue	659.07M
Gross Profit	95.00M
Operating Income	-65.26M
Pretax Income	-160.41M
Net Income	-162.15M
EBITDA	538,357
EBIT	-65.26M
Loss Per Share	-0.92

Full Income Statement

Balance Sheet

The company has 328.14 million in cash and 363.39 million in debt, giving a net cash position of -35.25 million.

Cash & Cash Equivalents	328.14M
Total Debt	363.39M
Net Cash	-35.25M
Net Cash Per Share	n/a
Equity (Book Value)	787.71M
Book Value Per Share	4.44
Working Capital	279.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.07 million and capital expenditures -97.14 million, giving a free cash flow of -82.08 million.

Operating Cash Flow	15.07M
Capital Expenditures	-97.14M
Free Cash Flow	-82.08M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 14.41%, with operating and profit margins of -9.90% and -24.60%.

Gross Margin	14.41%
Operating Margin	-9.90%
Pretax Margin	-24.34%
Profit Margin	-24.60%
EBITDA Margin	0.08%
EBIT Margin	-9.90%
FCF Margin	n/a

Dividends & Yields

Evotec SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-14.56%
FCF Yield	-7.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evotec SE has an Altman Z-Score of 1.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.1
Piotroski F-Score	n/a